Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000094.xml
Z Gastroenterol 2006; 44(7): 609-610
DOI: 10.1055/s-2006-926668
DOI: 10.1055/s-2006-926668
Kommentierte Referate
© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York
Pyoderma gangraenosum bei chronisch-entzündlichen Darmerkrankungen: eine neue Infliximab Domäne?
Infliximab for the Management of Pyoderma Gangrenosum in Inflammatory Bowel Disease: One for All?Further Information
Publication History
Publication Date:
05 July 2006 (online)
Brooklyn TN, Dunnill GS, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes AE, Greenwood R, Probert CS. Infliximab for the Treatment of Pyoderma Gangrenosum: a Randomised, Double-Blind Placebo-Controlled Trial Gut. Published Online First: 27 September 2005. doi:10.1136/gut.2005.074815
Priv.-Doz. Dr. D. C Baumgart
Charité Medical Center - Virchow Hospital, Medical School of the Humboldt-University, Department of Medicine, Division of Hepatology & Gastroenterology
13344 Berlin
Email: daniel.baumgart@charite.de